Brilinta DaYu Study
NCT01870921 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2004
Last updated 2018-04-03
Summary
A multicenter, single arm, open label, Phase IV study to evaluate safety and to describe the incidence of major cardiovascular events of ticagrelor in Chinese patients with acute coronary syndrome
Conditions
- Acute Coronary Syndrome
Interventions
- DRUG
-
Ticagrelor
90mg/tablet, 1 tablet bid
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Runlin Gao, Doctor · Fu Wai Hospital, Beijing, China
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 130 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-26
- Primary Completion
- 2015-09-30
- Completion
- 2015-09-30
Countries
- China
Study Locations
More Related Trials
-
Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina
NCT02284048 ·Status: UNKNOWN ·Phase: PHASE4
-
A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular Damage
NCT02214654 ·Status: UNKNOWN
-
Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor
NCT01883869 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction
NCT04610892 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
NCT01587651 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiovascular Inflammation Reduction Trial
NCT01594333 ·Status: COMPLETED ·Phase: PHASE3
-
DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury
NCT02110303 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting
NCT02487732 ·Status: COMPLETED ·Phase: PHASE4
-
In the Real World Study, the Efficacy and Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular Disease
NCT05716646 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery Stenosis
NCT06899399 ·Status: RECRUITING ·Phase: NA
-
A Prospective, Experimental, Multicenter, Open-label, Randomized, Controlled Trial of 3-month Dual Antiplatelet Therapy Followed by Ticagrelor Versus 6-month Dual Antiplatelet Therapy Followed by Ticagrelor After Implanting Bridge
NCT06301776 ·Status: RECRUITING ·Phase: NA
-
Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis
NCT02298088 ·Status: COMPLETED ·Phase: PHASE3
-
A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients
NCT04307511 ·Status: RECRUITING ·Phase: PHASE4
-
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
NCT06215989 ·Status: RECRUITING ·Phase: NA
-
Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake
NCT01690884 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Impact of 11-month Ticagrelor Monotherapy Following One-month DAPT After PCI
NCT05015699 ·Status: WITHDRAWN ·Phase: NA
-
Testing P2Y12 Platelet Inhibitors Generics Beyond Bioequivalence
NCT05474053 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study to Evaluate the Safety and Preliminary Efficacy of SGC001 in Patients With Myocardial Infarction
NCT07091929 ·Status: COMPLETED ·Phase: PHASE1
-
The ACS Ethnicity Platelet Function Study
NCT01829659 ·Status: COMPLETED
-
Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina
NCT01659580 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.
NCT01226602 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI)
NCT00320502 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old
NCT04122170 ·Status: COMPLETED ·Phase: PHASE2
-
Ticagrelor and Endothelial Function
NCT02261922 ·Status: UNKNOWN ·Phase: PHASE4
-
Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.
NCT04069234 ·Status: WITHDRAWN ·Phase: PHASE3